Physician profile
Syed Ali
NPI 1760612014
$19,207.17
in general payments reported to CMS, 2019-2025
19 companies · $7,624 in 2025
The $7,624 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $352 · 2021: $1,201 · 2022: $4,680 · 2023: $2,258 · 2024: $2,983 · 2025: $7,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,759 · Food and Beverage: $4,104 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,759.09 |
| Food and Beverage | $4,103.82 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $8,217.73 | 2020-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $3,557.01 | 2021-2025 | Triclip, Mitraclip |
| Boston Scientific Corporation | $2,841.41 | 2022-2024 | Watchman Flx |
| Medtronic, INC. | $2,581.86 | 2022-2025 | Corevalve Evolut R |
| Penumbra, INC. | $1,229.16 | 2025 | Ruby Coil |
| Abiomed | $389.25 | 2023-2025 | Impella |
| Biotronik INC. | $117.34 | 2022 | |
| Astellas Pharma US INC | $50.22 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $36.01 | 2025 | Exparel |
| Daiichi Sankyo INC. | $25.00 | 2023 | Injectafer |
| Amgen INC. | $24.21 | 2023 | Repatha |
| Medtronic Vascular, INC. | $22.06 | 2020 | |
| Terumo Medical Corporation | $20.45 | 2021 | |
| Merck Sharp & Dohme LLC | $19.05 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.89 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $16.55 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $15.99 | 2019 | |
| Teleflex LLC | $12.67 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.